Anticoagulant Regimens Linked to Higher Major Bleeding Risk Than Single Antiplatelet Therapy – International Journal of Stroke
International Journal of Stroke shared a post on X about a recent article by Sohei Yoshimura et al., adding:
“Study finds oral anticoagulant alone and DOAC with antiplatelet therapy were associated with higher risks of major bleeding events than single antiplatelet therapy.”
Title: Long-term risk of bleeding events in patients taking antithrombotic agents for cerebrovascular or cardiovascular disease
Authors: Sohei Yoshimura, Kaori Miwa, Masatoshi Koga, Kanta Tanaka, Yoshiki Yagita, Yoshinari Nagakane, Haruhiko Hoshino, Tadashi Terasaki, Masayuki Shiozawa, Yasuyuki Iguchi, Shuji Arakawa, Shigeru Fujimoto, Yasushi Okada, Masafumi Ihara, Shinichi Takahashi, Ryosuke Doijiri, Makoto Sasaki, Yusuke Yakushiji, Teruyuki Hirano, Kazunori Toyoda
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:30Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF
-
Oct 12, 2026, 21:28Michael Megaly: Does Coronary Ectasia Affect Outcomes in Acute Coronary Syndromes?
-
Oct 12, 2026, 21:25Vitor Borin P. de Souza: Think Twice Before Anticoagulating an Isolated Subsegmental PE
-
Oct 12, 2026, 20:43Jazlyn A Selvasingh: Excited to Share Our Research at AAO-HNSF 2026 in Los Angeles
-
Oct 12, 2026, 20:31Natalia Kovtun: Higher Ferritin Cutoffs Now Define Iron Deficiency
-
Oct 12, 2026, 19:39Edward Loftus: Using Low-Dose Aspirin in Pregnant Women With IBD
-
Oct 12, 2026, 19:32Shruti Sachdeva: Strengthening the Fight against Anemia